You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Hip Arthroplasty
Hip Arthroplasty
Johnson & Johnson MedTech has a breadth of experience in hip surgery. DePuy Synthes & Ethicon are collaborating to provide a total end-to-end procedural solution (“From Skin to Bone to Home”) - offering innovations designed to help hip patients get home sooner.
It’s the close that counts.
Working as one company to support hip surgery to help your patients from skin, to bone, to home. At DePuy Synthes, we strive to create class-leading implants, technique-inclusive offerings, and innovative technologies in hip replacement and reconstruction that enable surgeons to create truly customised solutions for every patient that Keep People Moving.
Soft tissue management is an important component of orthopaedic surgery. At Ethicon, we aim to show our orthopaedic customers how optimal soft tissue management 'can help improve patient outcomes, lower resource utilisation, and reduce cost.'
Wound Closure
STRATAFIX™
With significantly more points of fixation than traditional sutures, STRATAFIX™ Knotless Tissue Control Devices allowed for more consistent tension control over every pass and combined the strength* and security‡ of interrupted closure with the speed† of continuous closure.¤2-6
Plus Antibacterial Sutures
Triclosan-coated sutures have been shown in multiple meta- analyses to reduce the risk of SSIs by 28%. 7-9 Plus Antibacterial Sutures have been shown in vitro to inhibit bacterial colonization of the suture for 7 days or more and are effective against the most common organisms associated with SSIs¤10-12:
- Staphylococcus aureus
- Staphylococcus epidermidis
- MRSA
- MRSE
- Escherichia coli**
- K pneumoniae**
DERMABOND™ PRINEO™
DERMABOND™ PRINEO™ Skin Closure System provided a flexible microbial barrier with 98.43% protection in vitro for 72 hours against organisms commonly responsible for SSIs. ¥§ 13
DERMABOND™ PRINEO™ led to greater overall patient satisfaction compared to skin staples.¶ 14-16
Traditional wound closure techniques involving conventional suture, staples and wound dressings may not be the optimal choice to achieve the primary objective of multi-layer, watertight closure.17
Reducing risk factors and improving healing can be achieved with appropriate surgical technique and postoperative care. You can optimise tissue management through the principles of wound healing: gentle handling of tissues, careful haemostasis, obliteration of dead space, and avoidance of tension.18,19 Appropriate choice of wound dressing should manage wound bioburden, limit cross contamination and promote a wound healing environment. 20
STRATAFIX™ increased wound-holding security without knots5, 6, 21 ¤ || ¤¤
STRATAFIX™ provided better watertight closure21 †† ¤ ‡‡
STRATAFIX™: the only antibacterial barbed suture22-25 ββ ¤ β
STRATAFIX™: the only barbed suture appropriate for fascia2, 26 ‡‡ ¤
STRATAFIX™: faster ¶¶, stronger §§, more secure¥¥, 2, 5, 6, 27, 28
STRATAFIX™ Symmetric demonstrated superior tissue holding strength2 ##
Let’s work together to reduce infection risk, shorten length of stay and minimise readmissions.
DERMABOND™ PRINEO™ Skin Closure System vs. traditional sutures and staples respectively, were associated with:
Close faster with DERMABOND™ PRINEO™29 $$ #
DERMABOND™ PRINEO™: 98.43% protection13 § €
DERMABOND™ PRINEO™ reduced readmission rates30, 31 \\ $
DERMABOND™ PRINEO™ allows for visibility of the wound32, 33 Ω
DERMABOND™ PRINEO™: less post-op care14 Ω Ω
DERMABOND™ PRINEO™ increased patient satisfaction14-16 ¶
Care4today
Ethicon Home
Ethicon Customer Support
